Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRWD1 intronic transcript 1 (BRWD1-IT1) is a non-coding RNA species transcribed from the intronic regions of the BRWD1 gene. Its biological function, disease relevance, and role as a therapeutic target are not established. BRWD1, the parent gene, encodes an epigenetic regulator that remodels chromatin and is essential for proper B cell development in mammals, with mutations causing B cell deficiencies[1][2]. No evidence positions BRWD1-IT1 as a druggable receptor, enzyme, or biomarker. Its mention may arise from transcriptomic studies cataloging non-coding RNAs or intronic transcripts, but it is not supported as a canonical target in structured drug discovery or disease literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRWD1 intronic transcript 1 (BRWD1-IT1).